Suk Kim Selected Research

Brucellosis (Malta Fever)

9/2021	Immune-metabolic receptor GPR84 surrogate and endogenous agonists, 6-OAU and lauric acid, alter Brucella abortus 544 infection in both in vitro and in vivo systems.
1/2021	Prostaglandin I2 (PGI2) inhibits Brucella abortus internalization in macrophages via PGI2 receptor signaling, and its analogue affects immune response and disease outcome in mice.
6/2020	Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
3/2020	Adenosine receptor Adora2b antagonism attenuates Brucella abortus 544 infection in professional phagocyte RAW 264.7 cells and BALB/c mice.
1/2020	Immunization With a Combination of Four Recombinant Brucella abortus Proteins Omp16, Omp19, Omp28, and L7/L12 Induces T Helper 1 Immune Response Against Virulent B. abortus 544 Infection in BALB/c Mice.
11/2019	Interleukin 6 Promotes Brucella abortus Clearance by Controlling Bactericidal Activity of Macrophages and CD8+ T Cell Differentiation.
5/2019	Interleukin 1 alpha (IL-1α) restricts Brucella abortus 544 survival through promoting lysosomal-mediated killing and NO production in macrophages.
2/2019	Substantial Protective Immunity Conferred by a Combination of Brucella abortus Recombinant Proteins against Brucella abortus 544 Infection in BALB/c Mice.
10/2018	Emodin Successfully Inhibited Invasion of Brucella abortus Via Modulting Adherence, Microtubule Dynamics and ERK Signaling Pathway in RAW 264.7 Cells.
9/2018	Cytokines production and toll-like receptors expression in human leukemic monocyte cells, THP-1, stimulated with Brucella abortus cellular antigens.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suk Kim Research Topics

Disease

55	Infections 09/2021 - 07/2004
36	Brucellosis (Malta Fever) 09/2021 - 07/2003
14	Neoplasms (Cancer) 02/2022 - 04/2009
11	Inflammation (Inflammations) 03/2022 - 01/2007
6	Bacterial Infections (Bacterial Infection) 03/2022 - 05/2005
5	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2014
5	Bovine Brucellosis (Bang's Disease) 04/2016 - 06/2012
5	Pathologic Constriction (Stenosis) 10/2009 - 01/2005
4	Breast Neoplasms (Breast Cancer) 02/2022 - 12/2015
4	Body Weight (Weight, Body) 08/2021 - 03/2007
4	Hemorrhage 02/2011 - 01/2009
3	Hepatocellular Carcinoma (Hepatoma) 07/2019 - 12/2009
3	Thrombosis (Thrombus) 01/2019 - 01/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2012
2	Splenomegaly 05/2022 - 10/2019
2	Carcinoma (Carcinomatosis) 03/2022 - 04/2013
2	Liver Diseases (Liver Disease) 11/2021 - 10/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2021 - 03/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020 - 09/2020
2	Obesity 01/2020 - 10/2013
2	Stroke (Strokes) 01/2019 - 01/2005
2	Leiomyosarcoma 08/2018 - 12/2012
2	Ascites 03/2018 - 01/2017
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2017 - 04/2013
2	Autoimmune Diseases (Autoimmune Disease) 10/2016 - 01/2015
2	Tuberculosis (Tuberculoses) 05/2015 - 06/2010
2	Arthritis (Polyarthritis) 10/2013 - 06/2013
2	Necrosis 03/2012 - 02/2011
2	Neoplasms, Cystic, Mucinous, and Serous 11/2011 - 11/2010
1	Coccidiosis 07/2022
1	Hepatomegaly 05/2022
1	Gallbladder Neoplasms (Gallbladder Cancer) 03/2022
1	Triple Negative Breast Neoplasms 02/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2021
1	Weight Gain 08/2021

Drug/Important Bio-Agent (IBA)

16	CytokinesIBA 05/2022 - 06/2013
13	Proteins (Proteins, Gene)FDA Link 02/2019 - 03/2010
11	VaccinesIBA 02/2019 - 01/2013
8	AntigensIBA 09/2018 - 05/2007
7	Interleukin-10 (Interleukin 10)IBA 09/2021 - 01/2018
6	Interleukin-6 (Interleukin 6)IBA 05/2022 - 10/2016
5	Pharmaceutical PreparationsIBA 07/2022 - 09/2010
5	EnzymesIBA 03/2022 - 12/2008
5	Biological ProductsIBA 02/2022 - 12/2015
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 10/2016
4	Subunit VaccinesIBA 06/2020 - 02/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 10/2013
4	Therapeutic UsesIBA 06/2018 - 11/2011
3	gadolinium ethoxybenzyl DTPA FDA Link 11/2021 - 10/2009
3	LipidsIBA 01/2021 - 07/2004
3	Interleukin-12 (IL 12)IBA 05/2020 - 10/2019
3	Interferon-gamma (Interferon, gamma)IBA 11/2019 - 05/2005
3	Recombinant ProteinsIBA 02/2019 - 01/2016
3	Actins (F Actin)IBA 01/2018 - 02/2016
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 06/2012
3	Messenger RNA (mRNA)IBA 10/2016 - 03/2010
2	Phenobarbital (Luminal)FDA Link 02/2022 - 05/2009
2	BerberineIBA 08/2021 - 12/2017
2	InterleukinsIBA 01/2021 - 01/2018
2	Gemcitabine FDA Link 09/2020 - 09/2020
2	130-nm albumin-bound paclitaxelIBA 09/2020 - 09/2020
2	folfirinoxIBA 09/2020 - 09/2020
2	NitritesIBA 05/2020 - 04/2020
2	Interleukin-23 (Interleukin 23)IBA 01/2020 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 05/2019 - 12/2013
2	AlbuminsIBA 03/2019 - 10/2013
2	gintoninIBA 01/2019 - 01/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2018 - 01/2018
2	InterferonsIBA 11/2018 - 01/2018
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2018 - 01/2018
2	Antimicrobial PeptidesIBA 11/2018 - 10/2017
2	Gallic AcidIBA 06/2018 - 08/2017
2	Tannic Acid FDA Link 01/2018 - 08/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 03/2010
2	Adenosine Monophosphate (AMP)IBA 10/2017 - 10/2016
2	APTIBA 10/2017 - 10/2016
2	TanninsIBA 08/2017 - 01/2012
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2017 - 03/2012
2	Alanine Transaminase (SGPT)IBA 03/2017 - 03/2012
2	AntibodiesIBA 04/2016 - 08/2005
2	ImmunosorbentsIBA 06/2015 - 12/2008
2	Collagen Type II (Type II Collagen)IBA 10/2013 - 06/2013
2	Virulence Factors (Pathogenicity Factors)IBA 01/2013 - 08/2012
2	Galla RhoisIBA 01/2012 - 11/2011
2	MucinsIBA 11/2011 - 11/2010
2	Contrast MediaIBA 04/2010 - 02/2010
1	Amylases FDA Link 03/2022
1	A-130A (A 130)IBA 02/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	lauric acid (dodecanoic acid)IBA 09/2021
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 09/2021

Therapy/Procedure

8	Therapeutics 09/2020 - 01/2005
6	Stents 07/2011 - 01/2005
4	Pancreaticoduodenectomy 08/2021 - 04/2013
3	Microspheres (Microsphere) 01/2014 - 05/2007
2	Pancreatectomy 08/2021 - 12/2011
2	Palliative Care (Palliative Therapy) 01/2017 - 07/2011
1	Urinary Diversion (Ileal Conduit) 08/2021
1	Cystectomy 08/2021